Mcrae Capital Management Inc Abb Vie Inc. Transaction History

Mcrae Capital Management Inc

$486 Million
Q3 2024

A detailed history of Mcrae Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Mcrae Capital Management Inc holds 1,964 shares of ABBV stock, worth $355,758. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,964

Previous 1,940 1.24%

Holding current value

$355,758

Previous $332,000 16.57%

% of portfolio

0.08%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $3,932 - $4,783	24 Added 1.24%	1,964 $387,000
Q2 2024 Jul 24, 2024	SELL	$154.79 - $180.76 $123,832 - $144,608	-800 Reduced 29.2%	1,940 $332,000
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $4,155 - $4,734	-26 Reduced 0.94%	2,740 $498,000
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $3,445 - $4,287	26 Added 0.95%	2,766 $372,000
Q3 2022 Oct 20, 2022	SELL	$134.21 - $153.93 $2,281 - $2,616	-17 Reduced 0.62%	2,740 $368,000
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $8,945 - $11,372	65 Added 2.41%	2,757 $422,000
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $2,148 - $2,718	-20 Reduced 0.74%	2,692 $364,000
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $10,640 - $12,078	-100 Reduced 3.56%	2,712 $293,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $526 - $586	-5 Reduced 0.18%	2,812 $317,000
Q2 2020 Jul 23, 2020	SELL	$73.37 - $98.18 $1,394 - $1,865	-19 Reduced 0.67%	2,817 $277,000
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $27,025 - $40,974	419 Added 17.34%	2,836 $216,000
Q4 2019 Jan 17, 2020	BUY	$72.13 - $90.25 $174,338 - $218,134	2,417 New	2,417 $214,000
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $196,308 - $236,019	-3,117 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$65.7 - $83.98 $6,570 - $8,398	-100 Reduced 3.11%	3,117 $227,000
Q1 2019 Apr 16, 2019	SELL	$77.14 - $90.79 $74,440 - $87,612	-965 Reduced 23.08%	3,217 $259,000
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $77,850 - $96,010	-1,000 Reduced 19.3%	4,182 $386,000
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $22,227 - $24,710	250 Added 5.07%	5,182 $490,000
Q2 2018 Jul 16, 2018	BUY	$89.78 - $106.23 $66,437 - $78,610	740 Added 17.65%	4,932 $457,000
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $9,201 - $12,321	100 Added 2.44%	4,192 $397,000
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $285,826 - $365,088	4,092	4,092 $364,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcrae Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcrae Capital Management Inc with notifications on news.

Account

Mcrae Capital Management Inc Abb Vie Inc. Transaction History